...
首页> 外文期刊>Journal of vascular and interventional radiology: JVIR >Percutaneous occlusion of the left subclavian and celiac arteries before or during endograft repair of thoracic and thoracoabdominal aortic aneurysms with detachable nitinol vascular plugs.
【24h】

Percutaneous occlusion of the left subclavian and celiac arteries before or during endograft repair of thoracic and thoracoabdominal aortic aneurysms with detachable nitinol vascular plugs.

机译:经可拆卸的镍钛合金血管栓塞行胸腔和胸腹主动脉瘤的内移植修复前或过程中,左锁骨下和腹腔动脉经皮闭塞。

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE: To review an experience with the Amplatzer vascular plug (AVP) for prevention of type II endoleaks during endovascular aneurysm repair (EVAR) of thoracic and thoracoabdominal aneurysms. MATERIALS AND METHODS: Retrospective review was undertaken of 14 patients undergoing transcatheter occlusion of the left subclavian (n = 12) or celiac artery (n = 2) with the AVP as part of EVAR of thoracic and thoracoabdominal aneurysms at a single institution. Procedural criteria evaluated were success at target vessel occlusion, the number of AVPs used, use of adjunctive embolization devices, and embolization-related ischemic end-organ events. Follow-up imaging criteria included evaluation of persistent target vessel occlusion, evidence of device migration, and the presence and characterization of endoleak secondary to AVP failure. RESULTS: Complete target vessel occlusion was documented for all cases. In six cases, more than one AVP was placed, with an average of 1.5 devices per patient. In two cases, adjunctive coils were placed. Computed tomographic or magnetic resonance angiography follow-up was available for all patients (mean follow-up, 419 days; range 28-930 d). No case showed evidence of device migration or type II endoleak resulting from AVP failure. There was a single instance of left subclavian artery recanalization without type II endoleak. There were no embolization-related ischemic end-organ events. CONCLUSIONS: Transcatheter arterial occlusion of the subclavian and celiac arteries with the AVP is a valuable adjunct to endografting in cases in which side branch embolization is necessary to extend the landing zone.
机译:目的:回顾Amplatzer血管塞(AVP)在预防胸腔和胸腹动脉瘤的血管内动脉瘤修复(EVAR)过程中II型内漏的经验。材料与方法:回顾性研究了14例行经导管闭塞左锁骨下(n = 12)或腹腔动脉(n = 2)的患者,该患者在同一机构接受AVP作为胸腔和胸腹动脉瘤EVAR的一部分。评估的程序标准为目标血管闭塞成功,使用的AVP数量,辅助栓塞装置的使用以及栓塞相关的缺血性终末器官事件。随访的影像学标准包括评估永久性靶血管阻塞,器械迁移的证据以及继AVP衰竭后内漏的存在和特征。结果:所有病例均记录了完全的目标血管阻塞。在六种情况下,放置了一个以上的AVP,平均每位患者使用1.5台设备。在两种情况下,放置辅助线圈。所有患者均可进行计算机体层摄影或磁共振血管造影随访(平均随访,419天;范围28-930 d)。没有病例显示出因AVP失败而导致的设备迁移或II型内漏的迹象。仅有一例左锁骨下动脉再通而没有II型内漏。没有栓塞相关的缺血性终末器官事件。结论:在需要侧支栓塞以扩大着陆区的情况下,锁骨下动脉和腹腔动脉的经导管动脉闭塞是AVP的重要辅助手段。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号